Facial recognition used to identify Lafayette Square protester accused of assault
By Justin Jouvenal, Spencer Hsu,
The Washington Post
| 11. 22. 2020
A line of U.S. Park Police officers pushed protesters back from Lafayette Square on June 1, firing pepper balls and rolling canisters spewing irritant gas into the retreating crowds on H Street NW, video shows.
Amid screams and smoke, a man in a tie-dye T-shirt pulled an officer to the ground and punched him in the face, before disappearing into the chaos, according to charging documents.
The man grabbed another officer, before police caught up with him and attempted to make an arrest, authorities said. But the man wrestled free and vanished once again.
The protester might never have been identified, but an officer found an image of the man on Twitter and investigators fed it into a facial recognition system, court documents state. They found a match and made an arrest.
The court documents are believed to be the first public acknowledgment that authorities used the controversial technology in connection with the widely criticized sweep of largely peaceful protesters ahead of a photo op by President Trump. The case is one of a growing number nationwide in which...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...